<![CDATA[Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab]]>

ConferencetalquetamabNeutral

AI Analysis

Summary

Doctors Ajai Chari and Rahul Banerjee discuss emerging combination strategies with talquetamab for relapsed/refractory multiple myeloma to enhance T-cell-redirecting therapy efficacy.

Importance:3/10

Sentiment:

0.00

multiple myelomatalquetamabT-cell redirectioncombination therapyrelapsed/refractory

Related Companies

$FVNNU

Read the original article

Published by Cancer Network on July 17, 2026 12:05 PM

Read Original